| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jul 1, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jul 1, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Cadmium | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Kidney damage |
| Chromium | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Allergic dermatitis |
| Barium | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Increase in blood pressure |
| Thallium, Total | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| CYANIDE | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Nerve damage or thyroid problems |
| Selenium | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Mercury | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | Kidney damage |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 11 | Jun 30, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 11 | Jun 30, 2025 | Resolved | N/A |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Barium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increase in blood pressure |
| Barium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increase in blood pressure |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Nerve damage or thyroid problems |
| CYANIDE | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Nerve damage or thyroid problems |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Allergic dermatitis |
| Chromium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Allergic dermatitis |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Mercury | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Antimony, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Thallium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Selenium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Hair or fingernail loss; numbness in fingers or toes; circulatory problems |
| Cadmium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Kidney damage |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Beryllium, Total | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Barium | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | Increase in blood pressure |
| Combined Radium (-226 and -228) | Health-Based | N/A | 10 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 10 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 10 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 10 | Mar 31, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 10 | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Dec 31, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Dec 31, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Sep 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Health-Based | N/A | 8 | Sep 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jul 28, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jul 28, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Combined Radium (-226 and -228) | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 23, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 23, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 14, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 7, 2024 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Eye and nose irritation; stomach discomfort |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 26, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2023 | Active | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 13, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 11, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 11, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 11, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 23, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 23, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 1, 2023 | Active | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Chlorine | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Eye and nose irritation; stomach discomfort |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Ethylbenzene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Styrene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Toluene | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jul 6, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jul 6, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | May 9, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | May 9, 2021 | Resolved | N/A |